MAOA and prostate adenocarcinoma: Lapierre et al. used the double-knockout MAO-A/PTEN murine prostate adenocarcinoma model to reveal that these mice display an increment in prostatic markers of immune stimulation such as CD8+ T cells, granzyme B, and IFN-γ.